Atea cut to Underweight at Morgan Stanley citing concerns over oral COVID-19 drug
07 January 2022 - 5:07AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Atea Pharmaceuticals (NASDAQ:AVIR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Atea Pharmaceuticals (NASDAQ:AVIR)
Historical Stock Chart
From Apr 2023 to Apr 2024